These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13763647)

  • 1. [The corticotropin stimulus test by venous route in Cushings's syndrome].
    LOTTI P; IACOBELLI A; SORCINI G; MONTERVINO C; SCIARRA F; GIOVANNINI C
    Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Dec; 13():833-45. PubMed ID: 13763647
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary 17-keto-steroid and 17-ketogenic steroid excretion in Cushing's syndrome.
    HEIDER CH; HANDLEY CA; FORD RV
    J Clin Endocrinol Metab; 1959 Nov; 19():1471-6. PubMed ID: 14400611
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the urinary excretion of alpha-ketolic corticoids and aldosterone during Cushing's syndrome].
    ROMANI JD; ALBEAUX-FERNET M; CHABOT J
    Rev Med Fr; 1961 Jan; 42():15-6. PubMed ID: 24545746
    [No Abstract]   [Full Text] [Related]  

  • 4. [Content of steroids in the urine in Addison's disease and Itsenko-Cushing syndrome after ACTH administration].
    KHARVAT I; KANDRACH MSh
    Klin Med (Mosk); 1959 Jun; 37(6):51-61. PubMed ID: 13673498
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of corticotropin and 9alpha-fluorohydrocortisone on urinary steroids in Cushing's syndrome.
    JENKINS JS; SPENCE AW
    J Clin Endocrinol Metab; 1957 May; 17(5):621-31. PubMed ID: 13416372
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary 6 beta-hydroxy-cortisol in adrenocortical hyperfunction.
    TOUCHSTONE JC; BLAKEMORE WS
    J Clin Endocrinol Metab; 1961 Mar; 21():263-70. PubMed ID: 13777691
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary excretion of cortisol in Cushing's syndrome: effect of corticotropin.
    ROSS EJ
    J Clin Endocrinol Metab; 1960 Oct; 20():1360-5. PubMed ID: 13743606
    [No Abstract]   [Full Text] [Related]  

  • 8. [Excretion of delta-4, 3-ketocorticosteroids (INH-reactive) in normal and pathological conditions. Changes after stimulation with ACTH].
    BRANCACCIO A; D'ALESSANDRO B; IACONO G
    Prog Med (Napoli); 1959 Dec; 15():735-8. PubMed ID: 13803826
    [No Abstract]   [Full Text] [Related]  

  • 9. Abnormalities in N15 excretion rates after ingestion of tagged glycine in Cushing's syndrome and following ACTH administration.
    PARSON W; CRISPELL KR; EBBERT A
    J Clin Invest; 1952 Jun; 31(6):548-54. PubMed ID: 14938432
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diurnal variation of 17-OHCS and 17-KS in adreno-cortical diseases, particularly in Cushing's syndrome].
    HIROSE K
    Nihon Hinyokika Gakkai Zasshi; 1962 Jun; 53():448-55. PubMed ID: 13907666
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on Cushing's syndrome. I. Observations on the response of plasma 17-hydroxycorticosteroid levels to corticotropin.
    CHRISTY NP; LONGSON D; JAILER JW
    Am J Med; 1957 Dec; 23(6):910-6. PubMed ID: 13487609
    [No Abstract]   [Full Text] [Related]  

  • 12. Decreased or absent ACTH-like activity of blocked synthetic tricosapeptide.
    DANOWSKI TS; HOFMANN K; YAJIMA H; MOSES C
    Proc Soc Exp Biol Med; 1961 Dec; 108():559-61. PubMed ID: 13883467
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on the steroid excretion in a patient with a Cushing syndrome associated with a secondary myxedema due to hypophyseal tumor].
    Kleinfelder H; Husmann F
    Arch Klin Med; 1966; 212(2):129-42. PubMed ID: 4292111
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary formaldehydrogenic corticoid as determined after enzymatic hydrolysis in normal subjects and in patients with adrenal and hypertensive disease.
    DUSTAN HP; MASON HL; CORCORAN AC
    J Clin Invest; 1953 Jan; 32(1):60-7. PubMed ID: 13011209
    [No Abstract]   [Full Text] [Related]  

  • 15. Diurnal variation of 17-hydroxycorticosteroids, sodium, potassium, magnesium and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing's syndrome.
    DOE RP; VENNES JA; FLINK EB
    J Clin Endocrinol Metab; 1960 Feb; 20():253-65. PubMed ID: 13817162
    [No Abstract]   [Full Text] [Related]  

  • 16. [Determination of urinary steroids in adrenocortical hyperfunction].
    JAKOBSON T
    Duodecim; 1959; 75():808-17. PubMed ID: 13853081
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies in Cushing's syndrome. III. Urinary 17-ketosteroids in patients with bilateral adrenal cortical hyperplasia.
    JAILER JW; VANDE WIELE R; CHRISTY NP; LIEBERMAN S
    J Clin Invest; 1959 Feb; 38(2):357-65. PubMed ID: 13631067
    [No Abstract]   [Full Text] [Related]  

  • 18. [Unusually high values of tetrahydrocortexolone in the urine of 2 patients with the central form of Cushing's syndrome].
    Pinsker P; Bultasová H
    Cas Lek Cesk; 1967 Feb; 106(7):196-7. PubMed ID: 6045513
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cushing's syndrome caused by a non-endocrine pulmonary tumor].
    Hauger-Klevene JH
    Medicina (B Aires); 1966; 26(5):258-60. PubMed ID: 4297188
    [No Abstract]   [Full Text] [Related]  

  • 20. AN ALTERATION IN CORTISOL METABOLISM IN PATIENTS WITH CUSHING'S SYNDROME AND BILATERAL ADRENAL HYPERPLASIA.
    GUIGNARD-DEMAEYER JA; CRIGLER JF; GOLD NI
    J Clin Endocrinol Metab; 1963 Dec; 23():1271-84. PubMed ID: 14087608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.